1. Home
  2. MGF vs LONA Comparison

MGF vs LONA Comparison

Compare MGF & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Government Markets Income Trust

MGF

MFS Government Markets Income Trust

HOLD

Current Price

$2.85

Market Cap

95.2M

Sector

Finance

ML Signal

HOLD

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$9.82

Market Cap

90.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MGF
LONA
Founded
1987
2011
Country
United States
United States
Employees
N/A
19
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.2M
90.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MGF
LONA
Price
$2.85
$9.82
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
98.1K
35.8K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
7.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.82
$4.21
52 Week High
$3.14
$14.21

Technical Indicators

Market Signals
Indicator
MGF
LONA
Relative Strength Index (RSI) 39.60 49.10
Support Level N/A $8.10
Resistance Level $2.94 $9.88
Average True Range (ATR) 0.04 1.04
MACD -0.00 -0.10
Stochastic Oscillator 25.00 38.48

Price Performance

Historical Comparison
MGF
LONA

About MGF MFS Government Markets Income Trust

MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: